Summit Trail Advisors LLC Sells 2,752 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Summit Trail Advisors LLC decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,796 shares of the exchange traded fund’s stock after selling 2,752 shares during the period. Summit Trail Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $882,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in XBI. CWM LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 22.0% in the third quarter. CWM LLC now owns 10,239 shares of the exchange traded fund’s stock valued at $1,012,000 after purchasing an additional 1,849 shares during the period. ORG Wealth Partners LLC bought a new stake in SPDR S&P Biotech ETF during the 3rd quarter valued at $44,000. Creative Planning lifted its holdings in shares of SPDR S&P Biotech ETF by 15.6% in the 3rd quarter. Creative Planning now owns 29,114 shares of the exchange traded fund’s stock worth $2,876,000 after buying an additional 3,920 shares during the period. Swedbank AB bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $22,843,000. Finally, PFG Advisors increased its stake in shares of SPDR S&P Biotech ETF by 15.9% during the third quarter. PFG Advisors now owns 90,837 shares of the exchange traded fund’s stock valued at $8,975,000 after buying an additional 12,495 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $89.05 on Wednesday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The business has a 50-day moving average price of $92.23 and a 200 day moving average price of $96.30. The company has a market capitalization of $6.79 billion, a P/E ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.